Drug and Alcohol

12 Things You Need to Know About the FMCSA Clearinghouse

The Federal Motor Carrier Safety Administration (FMCSA) Drug & Alcohol Clearinghouse is a critical tool for the commercial transportation industry. It helps improve safety by tracking drug and alcohol violations for drivers with commercial driver’s licenses (CDLs) and commercial learner’s permits (CLPs). 

Common Issues to Watch Out for When Managing a DOT Random Drug and Alcohol Testing Program

For employers regulated by the Federal Motor Carrier Safety Administration (FMCSA), a compliant random drug and alcohol testing program is a required part of operating a safety-sensitive workforce. The rules are clear in principle. Drivers must be randomly selected for testing each year at the rates set by FMCSA. In practice, employers often encounter challenges that can affect compliance if the program is not carefully managed. 

U.S. Federal Marijuana Policy Update: What Employers Should Know

On December 18, 2025, U.S. President Donald Trump signed an executive order directing U.S. federal authorities to reclassify marijuana from a Schedule I to a less restrictive Schedule III controlled substance under U.S. federal law. This is a significant shift in long-standing U.S. federal drug policy, but it does not currently affect any DOT testing protocols.  

Impairing Prescription Medication Use & Fitness for Duty

At the recent Oil Sands Expo, DriverCheck’s Chief Medical Officer, Dr. Jonathan W. Davids, shared important insights during his presentation “Medication Madness: Impairing Prescription Medication Use & Fitness for Duty.” His talk highlighted the often-overlooked risks that prescription medications can pose in safety-sensitive industries.

Real Cases Real Solutions: Ensuring Workplace Safety with Post-Incident Drug Testing

In safety-sensitive environments, incorporating measures like post-incident drug testing helps ensure a thorough and responsible response to health-related incidents. By taking these steps, employers can ensure the safety and well-being of their employees while maintaining operational efficiency. 

OEMAC’s 2025 Position on Cannabis Use in Safety-Sensitive and Decision-Critical Work

The Occupational and Environmental Medical Association of Canada (OEMAC) has released an updated 2025 position statement addressing the implications of cannabis use in the workplace - specifically within safety-sensitive and decision-critical roles. These roles require high cognitive function and judgment, and impairment can lead to serious safety, performance, or interpersonal consequences.